Growth Metrics

Bespoke Extracts (BSPK) Common Equity (2016 - 2025)

Bespoke Extracts' Common Equity history spans 9 years, with the latest figure at -$2.6 million for Q3 2025.

  • On a quarterly basis, Common Equity fell 11.42% to -$2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.6 million, a 11.42% decrease, with the full-year FY2024 number at -$2.1 million, down 21.3% from a year prior.
  • Common Equity hit -$2.6 million in Q3 2025 for Bespoke Extracts, down from -$2.5 million in the prior quarter.
  • Over the last five years, Common Equity for BSPK hit a ceiling of $2.0 million in Q1 2022 and a floor of -$2.6 million in Q3 2025.
  • Historically, Common Equity has averaged -$930336.6 across 5 years, with a median of -$1.3 million in 2023.
  • Biggest five-year swings in Common Equity: surged 111.92% in 2021 and later tumbled 200.26% in 2023.
  • Tracing BSPK's Common Equity over 5 years: stood at -$79724.0 in 2021, then tumbled by 743.03% to -$672096.0 in 2022, then tumbled by 156.59% to -$1.7 million in 2023, then fell by 21.3% to -$2.1 million in 2024, then fell by 24.07% to -$2.6 million in 2025.
  • Business Quant data shows Common Equity for BSPK at -$2.6 million in Q3 2025, -$2.5 million in Q2 2025, and -$2.3 million in Q1 2025.